cephradine has been researched along with chitosan in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 2 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Machida, Y; Onishi, H; Takishima, J | 1 |
| Butt, A; Gull, N; Iqbal, SS; Islam, A; Jabeen, S; Khan, SM; Nisar, N; Yameen, B | 1 |
| Abbasi, SA; Ali, S; Andleeb, S; Awan, UA; Imdad, K; Mughal, TA; Nasreen, S; Raja, SA | 1 |
| Arshad, N; Qureshi, MAUR; Rasool, A | 1 |
4 other study(ies) available for cephradine and chitosan
| Article | Year |
|---|---|
Prolonged intestinal absorption of cephradine with chitosan-coated ethylcellulose microparticles in rats.
Topics: Animals; Cellulose; Cephradine; Chitin; Chitosan; Intestinal Absorption; Male; Microspheres; Rats; Rats, Wistar | 2002 |
Controlled release of cephradine by biopolymers based target specific crosslinked hydrogels.
Topics: Buffers; Cephradine; Chitosan; Delayed-Action Preparations; Drug Carriers; Drug Liberation; Galactans; Hydrogels; Hydrogen-Ion Concentration; Mannans; Osmolar Concentration; Plant Gums; Water | 2019 |
Screening of Antibacterial Efficacy of Chitosan Encapsulated Probiotics (Lactococcus lactis and Lactobacillus curvattus) against Clinical Bacterial Pathogens.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Buffaloes; Ceftriaxone; Cephalothin; Cephradine; Chitosan; Chloramphenicol; Ciprofloxacin; Erythromycin; Lactobacillus; Lactococcus lactis; Probiotics; Tetracyclines; Tobramycin | 2022 |
Graphene oxide reinforced biopolymeric (chitosan) hydrogels for controlled cephradine release.
Topics: Cephradine; Chitosan; Hydrogels; Hydrogen-Ion Concentration; Spectroscopy, Fourier Transform Infrared | 2023 |